News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
This Colorado Pharma May Not Have Enough Cash to Last 2017 3/24/2017
MEDA to Shut Down Facility But Employees Could Land a Gig at Neighboring Akorn Pharma 3/24/2017
How This New Jersey Biotech is Taking on Amgen (AMGN) 3/24/2017
Google (GOOG)'s Mysterious Biotech Calico Forms a Rare Deal With C4 Therapeutics 3/24/2017
Rumor Alert: Sanofi (SNY) Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal 3/23/2017
Teva (TEVA) Backpedals on 6,000 Job Cuts, Says Figure is Too High 3/23/2017
3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) 3/23/2017
Turns Out Editas Medicine (EDIT)'s R&D Deal With Allergan (AGN) Could be Worth $1 Billion 3/23/2017
5 Biotechs the Super-Rich Are Favoring in 2017 (So Far) 3/23/2017
Novartis AG (NVS)'s Phase III Drug for Heart Failure Bombs Trial 3/23/2017
Biogen (BIIB)'s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target 3/23/2017
How to Rework Your Resume to Make the Big Data Leap from Tech to Biotech 3/23/2017
4 Small-Cap Biotechs to Consider if Gilead (GILD) Isn’t Doing it For You 3/22/2017
Facebook Hiring Dozens for Secretive Division, Rumored to be Working on Brain-Scanning Technology and Other Med Device 3/22/2017
Ex-Novartis AG (NVS) Exec to Take the Reins at Bay Area's Forty Seven on May 1 3/22/2017
Former Celgene (CELG) Exec to Helm Cipher Pharma (DND.TO) 3/22/2017
Questions Arise Over This Bay Area Biotech CEO's Doctorate Degree and His Time at the University of Pennsylvania 3/21/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug 3/21/2017
Ex-GlaxoSmithKline (GSK) Scientists' Pulmocide Hauls in $30.4 Million 3/21/2017
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS) 3/21/2017
Disappointment Hits as Amgen (AMGN)'s Repatha Prevents Heart Attacks, But Not Deaths 3/20/2017
Fired U.S. Attorney Preet Bharara Was Investigating New HHS Chief Tom Price 3/20/2017
Biogen (BIIB) Faces Biggest One-Day Drop 3/20/2017
FDA Deals Another Blow to AstraZeneca PLC (AZN)'s Blood Drug 3/20/2017
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants 3/17/2017
Life Hack for Scientists: 9 Web-Savvy Tips to Get Your CV or Resume to the Top of an HR Search 3/17/2017
300 Employees Impacted as Teva (TEVA) to Shut Down or Sell Virginia Plant 3/16/2017
PTC Therapeutics (PTCT) Buys Marathon Pharma's Controversial $89,000-Per-Year DMD Drug for $190 Million 3/16/2017
Despite Expansion Overall, Roche Diabetes Care Lays Off 157 3/16/2017
Embattled Alexion (ALXN) Pink Slips 200+ Staffers in Restructuring 3/16/2017
Ex-Google (GOOG) Rock Star Decides to Raise $100 Million Biotech Venture Fund After All 3/16/2017
Meet the Teen Scientist Who Won Regeneron (REGN)'s Science Talent Search 2017 3/16/2017
Why Pfizer (PFE) Will Not Make Another Mega M&A Deal Anytime Soon 3/15/2017
3 Dazzling Biotechs Poised to Soar Even More 3/15/2017
Rumors Surface M&A-Desperate Gilead (GILD) is Nearing a Deal to Buy Incyte (INCY) 3/15/2017
Bay Area’s Dynavax (DVAX) Shifts Focus to Immune-Oncology, Cuts 40% of Staff 3/14/2017
2 Biotechs That Could Vanish by 2019 3/14/2017
Why This Biotech Has Amazon (AMZN)-Growth Potential 3/13/2017
3 Under-the-Radar Biotech Stocks to Check Out in March 3/13/2017
Troubled Cempra (CEMP) Looks for a Lifeline, Hires Morgan Stanley to Review Options 3/13/2017
Bay Area's Galena Biopharma  (GALE) Exploring Strategic Alternatives Just One Month After CEO Steps Down 3/13/2017
San Diego's Tocagen Goes for $86 Million IPO 3/13/2017
Argos (ARGS) Cuts Staff by 38% After Devastating Phase III News 3/10/2017
9 Questionable Drugs Biotechs Are Submitting to the FDA in a Hail Mary Pass 3/10/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO) 3/10/2017
3 Biotechs Under $5 With Jaw-Dropping Growth Potential 3/10/2017
President Trump Tosses Tweet-Bomb at Drug Industry, Stocks Drop 3/9/2017
Former Millennium and FORUM Pharma CEO Resurfaces to Helm Massachusetts Biotech XTuit 3/9/2017
Breath Therapeutics Holding BV Spins Out of PARI Pharma With $46 Million and a Ready-to-Go Phase III Drug/Device Combo 3/9/2017
Meet Mark Zuckerberg’s Man in the Lab at the Chan Zuckerberg Initiative 3/8/2017
Sanofi (SNY) Looking to Slap 'For Sale' Sign on Its European Generic Drug Biz, Deal Could Bring in $2.1 Billion 3/8/2017
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine (EDIT)’s HQ 3/8/2017
8 Biotechs That Could Be Taken Out Soon 3/7/2017
COO and First Employee of Editas Medicine (EDIT) to Exit, Effective March 31 3/7/2017
The Elephant in the Room—Investors Pushing for Lower Pay for 1st Female GlaxoSmithKline (GSK) CEO 3/7/2017
Vertex (VRTX) Inks Deal Worth $250 Million for Concert Pharma (CNCE)'s Cystic Fibrosis Drug 3/6/2017
Filings Reveal Billionaire Super-Investor Stocked Up on These 2 Biotech Stocks 3/6/2017
Rumor Alert: Novartis AG (NVS) In Talks to Buy NASH Biotech GENFIT (ALGFT) 3/6/2017
Eurofins Starts $59 Million Expansion, Creates 350 Jobs 3/6/2017
Sanofi Pasteur (SASY.PA) Inks $645 Million RSV Deal With AstraZeneca PLC (AZN)'s MedImmune (AZN) 3/6/2017
Scientists, Here’s the Best Elevator Pitch to Sell Yourself to a Potential Employer 3/3/2017
This Technical Skill Wanted for Cancer Research Jobs 3/3/2017
Getting on the Short List: 6+ Tips for Life Science Research Assistant Job Applications 3/2/2017
Roche (RHHBY) Reports Death in Phase III Hemophilia Study 2/27/2017
Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 2/24/2017
Why This 11-Employee Massachusetts Biotech's Market Cap Doubled Yesterday 2/24/2017
Serial Biotech Entrepreneur to Helm Biotech Startup FogPharma After Retiring From Harvard 2/24/2017
This Drug Could Rattle Biogen (BIIB) and Be the Next Billion-Dollar Blockbuster for Celgene (CELG) 2/23/2017
2 Biotechs That Had a Rough 2016 But May Be Poised for a Turnaround This Year 2/23/2017
These Are the 4 Most Admired Life Science Companies in the World 2/23/2017
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial 2/22/2017
This Tiny Biotech Grew 412% in 2016. A Look at Whether It Can Continue in 2017 2/22/2017
Moderna's Oncology Boss Reportedly Leaving Company 2/22/2017
4 Biopharma Stocks a Billionaire Investor Just Bought 2/22/2017
Pfizer (PFE) Continues $190 Million Expansion Plans in North Carolina 2/22/2017
Why ImmunoGen (IMGN) Investors are Waiting on Bated Breath to Move "FORWARD" 2/22/2017
5 Best U.S. Regions for Life Science Jobs 2/21/2017
The 10 Biggest Losers in Biopharma Last Year 2/21/2017
There Are Hints That Depomed (DEPO)’s Boss’s Days Are Numbered 2/21/2017
Six Ways to Drastically Improve Your Company’s Employment Brand 2/21/2017
Sarepta (SRPT) Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead (GILD) for $125 Million 2/21/2017
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos 2/20/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt 2/20/2017
New SoCal Biotech Jecure Therapeutics Makes Debut and Will Take on NASH 2/17/2017
SAGE Therapeutics (SAGE) Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity 2/17/2017
Bay Area Biotech Surrozen Launches With $33 Million and Could Double Its Headcount by Next Year 2/17/2017
A Look at Whether AbbVie (ABBV) Could Eventually Face the Same Issues as Gilead (GILD) 2/17/2017
How to Write the Best Cover Letter for a Research Scientist Job 2/16/2017
Why Secretive $5 Billion Biotech Moderna May Not be Able to Commercialize Products Into Clinical Trials 2/16/2017
With Ex-Juno (JUNO) Employees on Its Roster, Seattle's Silverback Therapeutics Files $10 Million Out of $60 Million Goal 2/16/2017
Bay Area Biotech Ardelyx (ARDX) Rejoices as Lead Drug Hits Phase III Goals 2/16/2017
Deal Spree Continues as Allergan (AGN) Inks $2.47 Billion Deal for This Bay Area Biotech 2/15/2017
All Signs Have Gilead (GILD) Gearing Up for a Much-Needed Acquisition 2/15/2017
Pfizer (PFE) Quietly Takes 16.4% Stake in This SoCal Medtech Firm 2/15/2017
Connecticut's Growing Biopharma Industry Looks to Fill High-Demand Jobs 2/15/2017
Why 2017 Could be a Transition Year for Booming Seattle Genetics (SGEN) 2/14/2017
This is How 47 Scientists Were Selected for the Chan-Zuckerberg Biohub 2/13/2017
Array BioPharma (ARRY) Has a Potential Blockbuster Melanoma Drug On Its Hands 2/13/2017
Daiichi Sankyo Shutters Yet Another R&D Facility 2/13/2017
Sarepta (SRPT) Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD 2/13/2017
Massachusetts' Tesaro (TSRO) Being Wooed by Multiple Suitors 2/10/2017
3 Biotech Stocks Able to Weather an Unstable Trump Administration 2/10/2017
I Am Woman, Hear Me Roar: GE Corporation (GE) Vows to Place 20,000 Women in Technical Roles By 2020 2/10/2017
How Gilead (GILD) Just Lost $9 Billion in Market Value This Week 2/10/2017
Reunited and It Feels So Good: After the Success of XO1, Serial Biotech Duo Launches SuperX 2/9/2017
Roche (RHHBY)/Genentech (RHHBY) to Upsize Biologics Manufacturing While Downsizing Small Molecule Manufacturing 2/9/2017
Out of 700+ Applications, Chan-Zuckerberg Biohub Puts 47 Scientists Under Payroll in Its Quest to Cure All Diseases 2/9/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III 2/8/2017
Heads Up, Startups: Bayer (BAY) is Bringing Its Grants4Apps Accelerator Program to San Francisco 2/8/2017
FDA to Publicly Disclose Advisory Committee Members' CVs 2/8/2017
4 Biotech Stocks Worthy Enough to be Brokers' Favorites 2/8/2017
Warning: Here's The Heartbreaking Truth About Postdoc Job Salaries in Life Sciences 2/8/2017
Attention Bay Area: Chan-Zuckerberg's BIOHUB is Hiring Lots of Scientists 2/8/2017
Genentech (RHHBY)'s $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire 2/8/2017
5 Highest Paid Biopharma CEOs of 2016 2/7/2017
2 Biotech Stocks That Could Be in Trouble if President Trump's Proposals Become Reality 2/7/2017
Merck KGaA (MKGAF.PK) Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials 2/7/2017
Always a Bridesmaid, Never a Bride: Acadia (ACAD) Moves Higher on Takeover Speculation 2/7/2017
AstraZeneca PLC (AZN) Quietly Kills Some Programs 2/6/2017
These 5 Biotechs Are Battling Over the $10 Billion Hemophilia Market 2/6/2017
Cash-Rich Amgen (AMGN) Joins the M&A Hunt for Big and Small Deals 2/6/2017
3 Biotechs Breathing Down Bristol-Myers Squibb (BMY)'s Neck 2/6/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering 2/3/2017
Explosion of Big Data Jobs: These Biotechs Are Hiring Huge Numbers of Data Scientists 2/3/2017
Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named 2/2/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs 2/2/2017
5 Highlights From Pfizer (PFE)'s 4th Quarter Conference Call 2/2/2017
2 Pharmas Set to Dominate the Future of Healthcare 2/1/2017
2 New Names Emerge as Possible Buyout Candidates for M&A Hungry Gilead (GILD) 2/1/2017
As Part of Digital Industrial Evolution, GE Corporation (GE) Lays Off an Undisclosed Number of Scientists in New York 2/1/2017
Catabasis (CATB) Plunges on DMD Drug Trial Failure 2/1/2017
The 3 Fastest Growing Drugs for Pfizer (PFE) 2/1/2017
Genentech (RHHBY)'s Oncology Boss Jumps Ship to Helm Bellicum (BLCM) 2/1/2017
Bill Gates Talks of Biotech as Top 3 Career Choices 2/1/2017
Roche (RHHBY) Not Looking to Unload Its Diabetes Biz After Rumors it May Exit 2/1/2017
6 Biopharma Companies Face Catalysts in February 1/31/2017
3 Possible Buyout Targets in Biotech Land 1/31/2017
Launching This Week, A Look at Biogen (BIIB)'s Spinoff Bioverativ (BIVVV) 1/30/2017
This Drug Could be Johnson & Johnson (JNJ)'s Next Billion-Dollar Blockbuster 1/30/2017
Ariad (ARIA) Stays Mum on Layoffs After Takeda (TKPYY)'s $5.2 Billion Takeover 1/30/2017
Novo Nordisk A/S (NVO) Pumps $145 Million in UK Diabetes Research Center, Investment Buys More British Scientists 1/30/2017
Why Amazon (AMZN) CEO Dropped Millions Into Bay Area's Unity Biotech 1/30/2017
Meet the 29 Year Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) 1/30/2017
Facebook Chief, Chan Charity Buys Artificial Intelligence Startup to Battle Disease 1/27/2017
It's Finally Happening: Johnson & Johnson (JNJ) Pays $30 Billion for Actelion (ALIOF.PK), Will Spin Off R&D Unit With $1 Billion Cash 1/27/2017
Celgene (CELG) Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia 1/27/2017
On a Roll, Seattle Genetics (SGEN) Plans to Hire 200 in 2017 1/26/2017
Social Media Rumors of Juno (JUNO) Acquisition Cause Stock Jitters 1/26/2017
Watch Out! Novartis AG (NVS) Hungry for Small Takeover Targets With Early-Stage Drugs 1/26/2017
3 Biotechs Most Likely to be Taken Out in 2017 1/25/2017
4 Biotechs to Make a Move On Now 1/25/2017
Kendall Square Upstart Cue BioPharma Comes Out of Stealth Mode With $26 Million 1/25/2017
Why Celgene (CELG) Should Consider Buying Rival Biogen (BIIB) 1/24/2017
Meet the 25-Year-Old CEO Helming Boston Cancer Startup ConquerX 1/24/2017
What You Need to Know About Homology Medicines 1/24/2017
What You Need to Know About Pliant 1/24/2017
Cellceutix (CTIX) CEO Unhinged After Anonymous Short Trader's Attacks 1/23/2017
Who Might or Might Not Buy Regeneron (REGN), And Why 1/23/2017
What You Need to Know About Fulcrum Therapeutics 1/23/2017
NIH Director to Keep Job Under Trump, for Now 1/23/2017
What You Need to Know About Arrivo BioVentures 1/23/2017
Theranos' Last Defender Claims Federal Witch Hunt 1/20/2017
9 Tips to Create the Best Clinical Research Resume or CV 1/20/2017
Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry 1/20/2017
A Peek Behind the Curtain of the Ariad (ARIA)-Takeda (TKPYY) Deal 1/20/2017
GlaxoSmithKline (GSK) Poaches AstraZeneca PLC (AZN) Exec to Replace Exiting Pharma Head 1/20/2017
5 Biotechs and the Drugs That May Put Them in Trump's Disfavor 1/20/2017
What You Need to Know About Decibel Therapeutics 1/20/2017
McKesson (MCK) to Pink Slip Some Employees in Wisconsin, Effective March 31 1/20/2017
What You Need to Know About Oncorus 1/20/2017
What Trump and His Potential Nominees Should Understand About the FDA 1/19/2017
Massachusetts' CoLucid Pharma (CLCD) Surges on $960 Million Eli Lilly (LLY) Buyout Deal 1/19/2017
Calling All Scientists: 7 Things You Need to Know About Paid Biotech Internships 1/19/2017
Anonymous Short Trader Attacks Cellceutix (CTIX) Again 1/19/2017
What You Need to Know About Ideaya 1/19/2017
What You Need to Know About Morphic Therapeutic 1/19/2017
Pfizer (PFE) CEO: What Trump Doesn't Understand About Pharma 1/19/2017
2017 Could be The Breakout Year for These 5 Biotechs 1/18/2017
Battered Ophthotech (OPHT) Cuts 80% of Staff After Failed Clinical Trials 1/18/2017
Meet the 27-Year Old CEO Who's Running Biotech Visikol 1/18/2017
Tiny Forward Pharma (FWP) Rockets on $1.25 Billion Cash Deal With Biogen (BIIB) 1/18/2017
Time to Get on the Train: 3 Biotechs That are About to Have Its Breakout Moment 1/18/2017
What You Need to Know About Adicet Bio 1/18/2017
What You Need to Know About Codiak BioSciences 1/18/2017
Genentech (RHHBY) Dealt a Blow From Massachusetts' Highest Court 1/17/2017
What You Need to Know About Tioma Therapeutics 1/17/2017
What You Need to Know About Blade Therapeutics 1/17/2017
Google (GOOG)'s Verily Pumps 1.4 Billion Euros Into Ireland; Expansion to Create 400 New Jobs 1/17/2017
Newly Created Fibrocor Therapeutics Makes Debut 1/17/2017
JPM17: Surprise! Pfizer (PFE) is Still Deal Hungry for M&As After Medivation (MDVN) 1/16/2017
What You Need to Know About GRAIL 1/16/2017
What You Need to Know About Petra Pharma 1/16/2017
Here's a Look at Allergan (AGN)'s Opportunity in NASH 1/16/2017
New Spinraza Data Has Biogen (BIIB) Screaming 'It's Worth It!' 1/16/2017
3 Little-Known Drugmakers That Deserve More Attention 1/13/2017
Struggling Nivalis (NVLS) Cuts 80% of Staff, Including CEO and CMO 1/13/2017
What You Need to Know About Forty Seven 1/13/2017
What You Need to Know About Semma Therapeutics 1/13/2017
Meet AstraZeneca PLC (AZN)'s New Head of Oncology 1/13/2017
Takeda (TKPYY) Takes a $125 Million+ Chance, Seals an Option to Buy Bay Area Startup Maverick Therapeutics 1/12/2017



//-->